Overland Therapeutics is a cross-border biotechnology company with a mission of accelerating the global development of first and best-in-class cell therapies. Headquartered in South San Francisco, Overland Tx has established fully integrated, cross-border cell therapy research, development, and GMP manufacturing capabilities. Overland Tx is developing both autologous and allogeneic cell therapies to address significant patient unmet needs in hematological malignancies and autoimmune diseases. For more information, please visit www.overlandtx.com.